Profound Medical (TSE:PRN)

Profound Medical (PRN) Financial Statements


Profound Medical Financial Overview

Profound Medical's market cap is currently ―. The company's EPS TTM is C$-1.872; its P/E ratio is -6.22; Profound Medical is scheduled to report earnings on March 7, 2024, and the estimated EPS forecast is C$-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 1.73M$ 1.60M$ 1.86M$ 1.26M$ 2.04M
Gross Profit$ 1.06M$ 1.51M$ 1.21M$ -506.00K$ 1.09M
EBIT$ -5.35M$ -7.13M$ -6.50M$ -9.43M$ -4.95M
EBITDA$ -5.35M$ -6.85M$ -6.22M-$ -4.58M
Net Income Common Stockholders$ -5.56M$ -7.36M$ -6.74M$ -9.53M$ -5.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 33.63M$ 39.27M$ 42.98M$ 46.52M$ 46.21M
Total Assets$ 50.44M$ 56.81M$ 61.24M$ 64.42M$ 64.08M
Total Debt$ 8.13M$ 8.29M$ 8.15M$ 8.23M$ 1.10M
Net Debt$ -25.50M$ -30.99M$ -34.84M$ -38.29M$ -45.11M
Total Liabilities$ 11.88M$ 12.44M$ 12.51M$ 12.42M$ 3.96M
Stockholders Equity$ 38.56M$ 44.37M$ 48.73M$ 52.00M$ 60.12M
Cash Flow-
Free Cash Flow-$ -5.12M$ -5.82M$ -6.62M$ -5.75M
Operating Cash Flow-$ -5.12M$ -5.82M$ -6.62M$ -5.75M
Investing Cash Flow----$ 0.00
Financing Cash Flow--$ 2.14M$ 7.01M$ 89.00K
Currency in USD

Profound Medical Earnings and Revenue History

Profound Medical Debt to Assets

Profound Medical Cash Flow

Profound Medical Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis